Ximoprofen
Alternative Names: 13832 JL; XIFAMLatest Information Update: 24 Oct 1997
At a glance
- Originator Logeais
- Class Antirheumatics; Nonsteroidal anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders
Most Recent Events
- 24 Oct 1997 Discontinued-Phase-Unspecified for Rheumatic disorders in France (PO)
- 10 Aug 1995 Suspended-Phase-Unspecified for Rheumatic disorders in France (PO)
- 08 Dec 1994 A new study involving patients with ankylosing spondylitis has been added to the therapeutic trials section